BioPharm News

May 25, 2016
In the largest-ever report of its kind, drugs entering clinical development in Phase I were found to have only a 1 in 10 chance of FDA approval.
May 25, 2016
By BioPharm International Editors
Sandoz is seeking approval for the same indications as Roche’s reference product MabThera.
May 24, 2016
By BioPharm International Editors
The companies have launched VEGF 165, their first joint product for cell culture applications.
May 24, 2016
By BioPharm International Editors
FDA accepted for review Samsung Bioepis’ BLA for SB2, a biosimilar to Remicade (infliximab).
May 23, 2016
By BioPharm International Editors
Sanofi announced that it is making several changes to its executive committee, effective June 1, 2016.
May 19, 2016
By BioPharm International Editors
Celgene will pay Agios $200 million to lead exploratory, research, drug discovery, and early development work for metabolic immuno-oncology.
May 19, 2016
Genentech received accelerated approval for its immunotherapy atezolizumab for the treatment of bladder cancer.
May 19, 2016
A new study in Nature Communications explores how to remove the bulk of the soaps that are added to injectables to make hydrophobic drugs more soluble.
May 18, 2016
By BioPharm International Editors
The NIH and partners will launch a large-scale clinical trial in South Africa to evaluate the effectiveness of an HIV vaccine regimen
May 18, 2016
By BioPharm International Editors
The agency detailed its 2015 achievements in an annual report.
lorem ipsum